Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma.

Pan XC, Li L, Mao JJ, Yao W, Zheng JN, Liu M, Fu JJ.

Oncol Lett. 2013 Jan;5(1):90-96. Epub 2012 Oct 12.

PMID:
23255900
[PubMed]
Free PMC Article
2.

Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo.

Xiao H, Huang B, Yuan Y, Li D, Han LF, Liu Y, Gong W, Wu FH, Zhang GM, Feng ZH.

Clin Cancer Res. 2007 Mar 15;13(6):1823-30. Epub 2007 Feb 26.

PMID:
17325342
[PubMed - indexed for MEDLINE]
Free Article
3.

[Construction of recombinant plasmid pIRES-GM-CSF-IL-21 and its therapeutic effect on orthotopically transplanted liver cancer in mice].

Cheng MR, Li Q, Hong XW, Ye T, He B, Cheng ZJ, Xu HZ, Zha BB.

Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):661-5. Chinese.

PMID:
22340045
[PubMed - indexed for MEDLINE]
4.

Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.

O'Malley BW Jr, Li D, McQuone SJ, Ralston R.

Laryngoscope. 2005 Mar;115(3):391-404.

PMID:
15744147
[PubMed - indexed for MEDLINE]
5.

Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma.

He L, Zhang G, He Y, Zhu H, Zhang H, Feng Z.

Anticancer Res. 2005 Sep-Oct;25(5):3309-13.

PMID:
16101143
[PubMed - indexed for MEDLINE]
Free Article
6.

Murine models of cancer cytokine gene therapy using interleukin-12.

Tahara H, Zitvogel L, Storkus WJ, Robbins PD, Lotze MT.

Ann N Y Acad Sci. 1996 Oct 31;795:275-83.

PMID:
8958939
[PubMed - indexed for MEDLINE]
7.

Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine.

He YF, Zhang GM, Wang XH, Zhang H, Yuan Y, Li D, Feng ZH.

J Immunol. 2004 Oct 15;173(8):4919-28.

PMID:
15470033
[PubMed - indexed for MEDLINE]
Free Article
8.

Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.

Nakano H, Kishida T, Asada H, Shin-Ya M, Shinomiya T, Imanishi J, Shimada T, Nakai S, Takeuchi M, Hisa Y, Mazda O.

J Gene Med. 2006 Jan;8(1):90-9.

PMID:
16097036
[PubMed - indexed for MEDLINE]
9.

Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.

Cao X, Wang Q, Ju DW, Tao Q, Wang J.

J Exp Clin Cancer Res. 1999 Jun;18(2):191-200.

PMID:
10464706
[PubMed - indexed for MEDLINE]
10.

Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.

Andrews KJ, Ribas A, Butterfield LH, Vollmer CM, Eilber FC, Dissette VB, Nelson SD, Shintaku P, Mekhoubad S, Nakayama T, Taniguchi M, Glaspy JA, McBride WH, Economou JS.

Cancer Res. 2000 Nov 15;60(22):6457-64.

PMID:
11103813
[PubMed - indexed for MEDLINE]
Free Article
11.

Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism.

Zhang J, Zhou Z, Wang C, Shen J, Zheng Y, Zhang L, Wang J, Xia D.

Cancer Immunol Immunother. 2011 Apr;60(4):559-73. doi: 10.1007/s00262-010-0955-5. Epub 2011 Jan 15.

PMID:
21240488
[PubMed - indexed for MEDLINE]
12.

Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.

Rosenthal FM, Cronin K, Bannerji R, Golde DW, Gansbacher B.

Blood. 1994 Mar 1;83(5):1289-98.

PMID:
8118032
[PubMed - indexed for MEDLINE]
Free Article
13.

Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.

Mendiratta SK, Quezada A, Matar M, Thull NM, Bishop JS, Nordstrom JL, Pericle F.

Hum Gene Ther. 2000 Sep 1;11(13):1851-62.

PMID:
10986558
[PubMed - indexed for MEDLINE]
14.
15.
16.

Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.

Belldegrun A, Tso CL, Sakata T, Duckett T, Brunda MJ, Barsky SH, Chai J, Kaboo R, Lavey RS, McBride WH, et al.

J Natl Cancer Inst. 1993 Feb 3;85(3):207-16.

PMID:
8423625
[PubMed - indexed for MEDLINE]
17.

Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.

Ju DW, Yang Y, Tao Q, Song WG, He L, Chen G, Gu S, Ting CC, Cao X.

Gene Ther. 2000 Oct;7(19):1672-9.

PMID:
11083476
[PubMed - indexed for MEDLINE]
Free Article
18.

NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.

Xu D, Gu P, Pan PY, Li Q, Sato AI, Chen SH.

Int J Cancer. 2004 Apr 20;109(4):499-506.

PMID:
14991570
[PubMed - indexed for MEDLINE]
19.

Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma.

Hu P, Hu HD, Chen M, Peng ML, Tang L, Tang KF, Matsui M, Belladonna ML, Yoshimoto T, Zhang DZ, Xiang R, Ren H.

Mol Immunol. 2009 May;46(8-9):1654-62. doi: 10.1016/j.molimm.2009.02.025. Epub 2009 Mar 18.

PMID:
19299021
[PubMed - indexed for MEDLINE]
20.

[Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].

Guo C, Liu QG, Yang W, Yao YM.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Feb;28(2):188-92. Chinese.

PMID:
18250039
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk